This collection
is approved on the condition that FDA revise the burden statement
to conform with the Paperwork Reduction Act of 1995.
Inventory as of this Action
Requested
Previously Approved
06/30/1998
06/30/1998
1,830
0
0
73,200
0
0
0
0
0
Manufacturers of biological products
are required to file an application for FDA reviw and approval
prior to marketing a product in interstate commerce. In addition,
changes to an approved application are required to be reported to
FDA. The above-referenced forms are used for submission of this
information. This information helps FDA ensure that biological
products are safe and effective.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.